{"id":15950,"date":"2012-12-10T03:30:00","date_gmt":"2012-12-10T02:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/olanda-generici-per-affrontare-carica-di-over-65\/"},"modified":"2012-12-10T03:30:00","modified_gmt":"2012-12-10T02:30:00","slug":"olanda-generici-per-affrontare-carica-di-over-65","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/olanda-generici-per-affrontare-carica-di-over-65\/","title":{"rendered":"Holland, generics to face charge of &#039;over 65&#039;"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\">The Netherlands is focusing on generic medicines to try to contain the costs associated with the progressive aging of the population, notes a new report by GlobalData. The percentage of the Dutch population &#039;over 65&#039;, in fact, increased from 14% in 2006 to 15.6% last year, and by the end of the decade a further +18.6% of elderly people over 65 is expected. <\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\">In 2008, health insurance companies introduced preferential policies, accompanied by lists of drugs with the same active ingredient but different prices. As a result, the prices of common generic drugs fell by an average of 85% in the following year. <\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\">Furthermore, the Government has allowed insurance companies to add i<span style=\"mso-spacerun: yes\">&nbsp; <\/span>biosimilars, in order to give further impetus to the &#039;non-designer&#039; sector. Thanks also to these measures, the value of the Dutch generics market grew from $832 million in 2005 to $1.8 billion in 2010, with a compound annual growth rate of 15%. <\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><font face=\"Calibri\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\">With major drug patent expirations in the near future, GlobalData predicts that the generics sector in the Netherlands will continue to expand, with great opportunities for generic companies<\/span><span style=\"font-family: BookAntiqua; color: #212120; font-size: 9pt; mso-bidi-font-family: BookAntiqua\">.<\/p>\n<p><\/span><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><i><span style=\"line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; color: #212120; font-size: 9pt; mso-bidi-font-weight: bold\">Paola Olgiati \u2013 February 10, 2012 \u2013 PharmaKronos<\/span><\/i><span style=\"line-height: 115%; font-size: 9pt\"><\/p>\n<p><\/span><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>I Paesi Bassi puntano sui farmaci equivalenti per cercare di contenere i costi legati al progressivo invecchiamento della popolazione, rileva un nuovo report di GlobalData. La percentuale di popolazione olandese &#8216;over 65&#8217;, infatti, &egrave; aumentata dal 14% del 2006 al 15,6% dell&#8217;anno scorso, ed entro la fine del decennio si prevede un ulteriore +18,6% di &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15950","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15950"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15950\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}